Artículos

  1. La reactivación del Herpes simple, requiere la vía específica de estrés neuronal JNK
  2. Nuevo brote de enterovirus, cepa D68, asociado con parálisis flácida
  3. Brote prolongado de infección por Mycobacterium chimaera después de cirugía a corazón abierto
  4. Hadal biosphere: Insight into the microbial ecosystem in the deepest ocean on Earth
  5. Brote de botulismo en personas que se inyectaron heroína en Noruega y el Reino Unido
  6. Enfermedad meningocócica invasora en el siglo 21- una puesta a punto para los clínicos
  7. Vacunas protectoras contra el paludismo
  8. Kamata, T., et al. “Determination of Specific Antibody Responses to the Six Species of Ebola and Marburg Viruses by Multiplexed Protein Microarrays,” Clinical and Vaccine Immunology, 2014, September. doi: 10.1128/CVI.00484-14 [e-pub ahead of print].
  9. Zaragozá R, el al. Épico 2.0 project. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Rev Iberoam Micol 2014; 31: 157-175.
  10. Ledgerwood JE, et al. Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report. NEJM. November 26, 2014DOI: 10.1056/NEJMoa1410863
  11. Kamata T, et al. Determination of Specific Antibody Responses to the Six Species of Ebola and Marburg Viruses by Multiplexed Protein Microarrays. Clin Vaccine Immunol 2014; 21: 1605-1612.
  12. Enoch D, Idris S, Aliyu S, Micallef C, Sule O, Micafungin For The Treatment Of Invasive Aspergillosis. Karas J; J Infect Chemother 2014; doi: 10.1016/j.jinf.2014.01.007
  13. Lee B, Gabardi S, Grafals M, Hofmann R, Akalin E, Aljanabi A, Mandelbrot D, Adey D, Heher E, Fan P, Conte S, Dyer-Ward C, Chandraker A;Efficacy of Levofloxacin in the Treatment of BK Viremia: A Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial. Clin J Amer Soc Nephrol, CJASN 2014; 9: 583-589
  14. Infecciones relacionadas con el uso de catéteres vasculares. Ferrer F, Almirante B. Enfer Infecc Microbiol Clin 2014; 32: 115-124.
  15. Millares L, Ferrari R, Gallego M, Garcia-Nuñez M, Pérez-Brocal V, Espasa M, Pomares X, Monton C, Moya A, Monsó E. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases 2014; [Epub ahead of print] DOI 10.1007/s10096-013-2044-0
  16. Bicanic TA, Harrison TS. Systemic fungal infections. Medicine 2014; 42: 26-30.
  17. Xu SX, Shen JL, Tang XF, Feng B. Newer Antifungal Agents for Fungal Infection Prevention During Hematopoietic Cell Transplantation: A Meta-Analysis. Transplantation Proceedings 2013: l. 45: 407-414.
  18. Tunnicliffe G, Schomberg L, Walsh S, Tinwell B, et al. Airway and parenchymal manifestations of pulmonary aspergillosis. Respir Med 2013; 107: 1113-1123.
  19. Sonication: A Valuable Technique for Diagnosis and Treatment of Periprosthetic Joint Infections. D.S. Evangelopoulus et al. The Scientific World Journal 2013, Article ID 375140.
  20. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diag Microbiol Infect Dis 2013; 77: 37-40.
  21. Antinori S, Corbellino M, Meroni L, Resta F, et al. Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect 2013; 66: 218-238.
  22. Spapen H, Spapen J, Taccone FS, Meersseman W, et al. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort. Inter J Antimicrob Agents 2014; 43: 165-169.
  23. Sonication: A Valuable Technique for Diagnosis and Treatment of Periprosthetic Joint Infections. D.S. Evangelopoulus et al. The Scientific World Journal 2013, Article ID 375140.
  24. Kono Y, Tsushima K, Yamaguchi K, Kurita N, et al. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Respir Med 2013: 107: 1094-1100.
  25. Agbetile J, Bourne M, Fairs A, Hargadon B, et al. Effectiveness of voriconazole in the treatment of Aspergillus fumigatus–associated asthma (EVITA3 study). J Aller Clin Immunol 2013; doi: 10.1016/j.jaci.2013.09.050
  26. Calderón-Gonzalez R, et al. Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH. Front. Cell. Infect. Microbiol., 21 February 2014 | doi: 10.3389/fcimb.2014.00022.
  27. Julián-Jiménez A, et al. Utilidad de los biomarcadores de inflamación e infección en los servicios de urgencias. Enferm Infect Microiol Clin 2014; 32: 177-190.
  28. Ferrer C, Almirante B. Infecciones relacionadas con el uso de los catéteres vasculares Enferm Infecc Microbiol Clin. 2014; 32: 115-124
  29. Michael Janda J. Shewanella: a Marine Pathogen as an Emerging Cause of Human Disease. Clin Microbiol Newsletter 2014; 36: 25-29.
  30. Peterson RL, et al. Role of Clinical Microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001; 32 :605-611.
  31. Tasas de infección quirúrgica en España: Resumen de datos, enero de 1997 hasta junio de 2012
  32. Asociación de Fusobacterium nucleatum con las etapas de desarrollo de neoplasia colorrectal, cáncer colorrectal y de evolución de la enfermedad
  33. Microbiota_bacteriana_del_tejido_mamario_humano
  34. InhibidorB-lactamsa
  35. ART Protesis cadera y adherencia bacteriana